Funds and ETFs Laboratory Corporation of America Holdings

Equities

LH

US50540R4092

Healthcare Facilities & Services

Real-time Estimate Cboe BZX 18:41:45 10/05/2024 BST 5-day change 1st Jan Change
207.2 USD +0.52% Intraday chart for Laboratory Corporation of America Holdings +2.94% -8.82%

ETFs positioned on Laboratory Corporation of America Holdings

Name Weight AuM 1st Jan change Investor Rating
0.09% 2 M€ +14.69% -
0.09% 0 M€ -.--% -
0.09% 0 M€ +8.31% -
0.09% 0 M€ +11.72%
0.08% 36 M€ +22.19%
0.08% 0 M€ +18.44% -
0.07% 1 M€ +0.04%
0.07% 0 M€ -.--%
0.07% 1,848 M€ +18.39% -
0.07% 559 M€ +14.30% -
0.07% 276 M€ +11.40% -
0.07% 6 M€ +17.98% -
0.06% 0 M€ +6.76% -
0.06% 0 M€ +12.11% -
0.06% 0 M€ +8.05%
0.06% 0 M€ +9.11% -
0.06% 0 M€ +19.88% -
0.05% 0 M€ +11.62% -
0.05% 0 M€ +18.92%
0.04% 786 M€ -.--%
0.04% 23 M€ -.--% -
0.04% 14 M€ +16.19% -
0.04% 206 M€ -.--%
0.04% 0 M€ 0.00% -
0.03% 0 M€ +6.75% -
Laboratory Corporation of America Holdings is the No. 2 clinical laboratory in the United States. Net sales (including intragroup) break down by activity as follows: - clinical laboratory services (63.9%): routine testing, patient diagnosis, disease monitoring and treatment, and other services; - development and clinical trial services (36.1%): for pharmaceutical, biotechnology, medical device and diagnostic companies. Net sales are distributed geographically as follows : North America (81.2%), Europe (12.7%) and other (6.1%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
206.2 USD
Average target price
239.6 USD
Spread / Average Target
+16.23%
Consensus
  1. Stock Market
  2. Equities
  3. LH Stock
  4. Funds and ETFs Laboratory Corporation of America Holdings